North Star Investment Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3K Hold
3,380
– – ﹤0.01% 904
2026
Q1
$16.2K Buy
3,380
+880
+35% +$5.69K ﹤0.01% 929
2025
Q4
$20.4K Hold
2,500
– – ﹤0.01% 834
2025
Q3
$14.7K Hold
2,500
– – ﹤0.01% 853
2025
Q2
$21K Buy
+2,500
New +$18.2K ﹤0.01% 783
2024
Q2
– Sell
-1,368
Closed -$21.5K – 1184
2024
Q1
$21.5K Hold
1,368
– – ﹤0.01% 729
2023
Q4
$21.3K Hold
1,368
– – ﹤0.01% 707
2023
Q3
$27.5K Buy
+1,368
New +$20.1K ﹤0.01% 687
2022
Q3
– Sell
-274
Closed -$6K – 1139
2022
Q2
$6K Hold
274
– – ﹤0.01% 906
2022
Q1
$8K Buy
+274
New +$10K ﹤0.01% 904
2021
Q4
– Sell
-99
Closed -$8K – 1187
2021
Q3
$8K Buy
+99
New +$8.67K ﹤0.01% 893

Other funds holding HELP

North Star Investment Management's HELP Position: Q2 2026 in Review

North Star Investment Management held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 3,380 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

North Star Investment Management first reported a position in HELP in Q3 2021 and has held it in 11 quarters since. The position peaked at $27.5K in Q3 2023. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • North Star Investment Management held 3,380 shares of Helus Pharma Inc. Common Stock worth $22.3K as of Q2 2026.
  • North Star Investment Management left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #904 holding.
  • North Star Investment Management first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 11 quarters since.
  • North Star Investment Management's Helus Pharma Inc. Common Stock position peaked at $27.5K in Q3 2023.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.